Company Profile

NuTech Medical and its regenerative medicine products are now a part of Organogenesis, Inc.  Our product portfolio offers a complete line of state-of-the-art products that take advantage of the unique healing properties of amniotic tissues and fluids.  These products are recognized for their excellent regenerative, anti-inflammatory, anti-scarring, and angiogenic properties.  Organogenesis, Inc. has a culture of scientific advancement and a strong commitment to product innovation and exceptional customer service, and is dedicated to providing new technologies that will benefit surgeons, hospitals, and most importantly, patients.

Our portfolio includes an amniotic product line for both soft tissue and bone applications, utilized in multiple markets including wound healing and surgery.  The product line includes Affinity®, an innovative, fresh amniotic allograft; NuShield®, a dehydrated terminally-sterilized allograft that comprises both the amnion and chorion layers; and NuCel® and ReNu®, cryopreserved allografts derived from human amnion and amniotic fluid, as well as other complementary products.  Our proprietary BioLoc™ process is the field’s state-of-the-art technology for preserving the native structure of the amnion and chorion membranes, optimized to provide excellent strength, flexibility, and handling.  Our proprietary AlloFresh™ process allows for the fresh hypothermic storage of amniotic tissues while retaining their structural integrity, viability, and native benefits.